SEC Form 4 · accession 0000357097-15-000052
Fibrocell Science, Inc. · FCSC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Marino III
Officer — SVP and General Counsel
Period of report
Jun 1, 2015
Accepted (ET)
Jun 2, 2015 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000357097
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF2,F1 | $4.76 | Jun 1, 2015 | A | 220,000 | A | — | Jun 1, 2025 | Common Stock | 220,000 | 220,000 | D |
Explanation of responses
- F1The options set forth in this table vest as follows: (i) 55,000 shares on June 1, 2016 and (ii) 13,750 for each of twelve quarterly installments beginning on September 1, 2016 and ending on June 1, 2019 provided the reporting person is employed by the Company on each vesting date.
- F2The options were issued in connection with the reporting person's employment service to the Company.